Multiechinocandin- and Multiazole-Resistant Candida parapsilosis Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis

AUTOR(ES)

Moudgal, Varsha

FONTE

American Society for Microbiology

RESUMO

Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)-resistant Candida strain during therapy.

Documentos Relacionados

• A case of prosthetic valve endocarditis caused by Corynebacterium hofmanni and Candida albicans.
• Aspergillus prosthetic valve endocarditis.
• Ultrastructure of Candida parapsilosis endocarditis.
• Plasmid pattern analysis of Staphylococcal epidermidis isolates from patients with prosthetic valve endocarditis.
• Bacillus licheniformis prosthetic aortic valve endocarditis.